Cogent Biosciences Inc (NASDAQ: COGT) kicked off on Friday, up 5.94% from the previous trading day, before settling in for the closing price of $34.7. Over the past 52 weeks, COGT has traded in a range of $3.72-$37.00.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 10.02%. While this was happening, its average annual earnings per share was recorded 8.10%. With a float of $122.89 million, this company’s outstanding shares have now reached $139.83 million.
Cogent Biosciences Inc (COGT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cogent Biosciences Inc is 19.18%, while institutional ownership is 87.37%. The most recent insider transaction that took place on Jul 10 ’25, was worth 24,999,993. In this transaction Director of this company bought 2,777,777 shares at a rate of $9.00, taking the stock ownership to the 9,003,418 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Commercial Officer bought 43,750 for $7.60, making the entire transaction worth $332,412. This insider now owns 45,848 shares in total.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.09 earnings per share (EPS), higher than consensus estimate (set at -0.58) by 0.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.19% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Take a look at Cogent Biosciences Inc’s (COGT) current performance indicators. Last quarter, stock had a quick ratio of 6.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.37, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.79 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Compared to the last year’s volume of 2.23 million, its volume of 3.55 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 87.26%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 98.93%, which indicates a significant increase from 98.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.63 in the past 14 days, which was higher than the 0.94 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.70, while its 200-day Moving Average is $10.74. Nevertheless, the first resistance level for the watch stands at $37.71 in the near term. At $38.67, the stock is likely to face the second major resistance level. The third major resistance level sits at $40.25. If the price goes on to break the first support level at $35.17, it is likely to go to the next support level at $33.59. Should the price break the second support level, the third support level stands at $32.63.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
The company with the Market Capitalisation of 5.59 billion has total of 142,377K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -255,860 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -80,930 K.
